Neue Produkte

Asserachrom® VIIa–AT

This innovating test is an indirect marker of Tissue Factor exposure In Vivo.


STA®-Rivaroxaban Calibrator & STA®-Rivaroxaban Control*

Rivaroxaban is a new oral anticoagulant developed by Bayer HealthCare and sold under the trade name Xarelto®. It is a direct factor Xa inhibitor approved for the prevention of VTE after hip or knee replacement surgery in more...


Asserachrom® VWF:FVIIIB

How can haemophilia A and type 2N von Willebrand disease be distinguished? To answer this question, Stago has developed a new diagnostic tool for VWF disease 2N: the Asserachrom® VWF:FVIIIB kit.


STA®-Liquid Anti-Xa: the solution of choice for UFH, LMWH and Fondaparinux monitoring

Stago offers a comprehensive range for anticoagulant monitoring. The new STA®-Liquid Anti-Xa is a specific, easy to use and reliable test. Fully automated test on STA® line analysers, it is the solution of choice for UFH, LMWH...


Asserachrom HPIA - IgG (Cat. Nr. 00624)

A New Tool for the Diagnosis and Exclusion of Heparin-Induced Thrombocytopenia (HIT)


 1 2 3 4